ACL australian clinical labs limited

News: ACL Healius Acknowledges Australian Competition & Consumer Commission Decision on ACL Takeover

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Dec 15 (Reuters) - Healius Ltd (HLS) :

    • ACCC REJECTION AND ACL NOTICE OF INTENTION TO WITHDRAW OFFER,ACL
    • ACKNOWLEDGES TODAY'S AUSTRALIAN COMPETITION & CONSUMER COMMISSION (ACCC) DECISION
    • DECISION TO OPPOSE PROPOSED ACQUISITION OF HEALIUS BY AUSTRALIAN CLINICAL LABS LIMITED
    • TAKEOVER OFFER WILL NOT BE PROCEEDING.
    • FURTHER ACKNOWLEDGES ANNOUNCEMENT BY ACL THAT IT INTENDS TO APPLY TO ASIC FOR CONSENT TO WITHDRAW ITS PROPOSED TAKEOVER OFFER FOR HEALIUS
    • HEALIUS WELCOMES TODAY'S ANNOUNCEMENTS FROM ACCC AND ACL
    • CONSENT IS NOT GRANTED, TAKEOVER OFFER TO LAPSE ON 29 FEB 2024
    • BOARD AND MANAGEMENT REMAINS FOCUSED ON RUNNING HEALIUS' BUSINESS IN BEST INTERESTS OF SHAREHOLDERS
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.60
Change
-0.030(1.14%)
Mkt cap ! $510.6M
Open High Low Value Volume
$2.64 $2.65 $2.59 $901.1K 345.8K

Buyers (Bids)

No. Vol. Price($)
3 18300 $2.60
 

Sellers (Offers)

Price($) Vol. No.
$2.62 2000 1
View Market Depth
Last trade - 16.10pm 05/09/2025 (20 minute delay) ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.